Open access · CC-BY
via OpenAlex
Stemming retinal regeneration with pluripotent stem cells
Zi‐Bing Jin, Mei-Ling Gao, Wen-Li Deng, Kun‐Chao Wu, Sunao Sugita, Michiko Mandai, Masayo Takahashi
Progress in Retinal and Eye Research · 2018 · ▲ 222 citations
Abstract
Cell replacement therapy is a promising treatment for irreversible retinal cell death in diverse diseases, such as age-related macular degeneration (AMD), Stargardt's disease, retinitis pigmentosa (RP) and glaucoma. These diseases are all characterized by the degeneration of one or two retinal cell types that cannot regenerate spontaneously in humans. Aberrant retinal pigment epithelial (RPE) cells can be observed through optical coherence tomography (OCT) in AMD patients. In RP patients, the morphological and functional abnormalities of RPE and photoreceptor layers are caused by a genetic abnormality. Stargardt's disease or juvenile macular degeneration, which is characterized by the loss of the RPE and photoreceptors in the macular area, causes central vision loss at an early age. Loss of retinal ganglion cells (RGCs) can be observed in patients with glaucoma. Once the retinal cell degeneration is triggered, no treatments can reverse it. Transplantation-based approaches have been proposed as a universal therapy to target patients with various concomitant diseases. Both the replacement of dead cells and neuroprotection are strategies used to rescue visual function in animal models of retinal degeneration. Diverse retinal cell types derived from pluripotent stem cells, including RPE cells, photoreceptors, RGCs and even retinal organoids with a layered structure, provide unlimited cell sources for transplantation. In addition, mesenchymal stem cells (MSCs) are multifunctional and protect degenerating retinal cells. The aim of this review is to summarize current findings from preclinical and clinical studies. We begin with a brief introduction to retinal degenerative diseases and cell death in diverse diseases, followed by methods for retinal cell generation. Preclinical and clinical studies are discussed, and future concerns about efficacy, safety and immunorejection are also addressed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.preteyeres.2018.11.003
- Canonical
- link ↗
- Fetched
- 2026-09-04 MST
Cite this
APA
Jin, Z., Gao, M., Deng, W., Wu, K., Sugita, S., Mandai, M., & Takahashi, M. (2018). Stemming retinal regeneration with pluripotent stem cells. <em>Progress in Retinal and Eye Research</em>. https://doi.org/10.1016/j.preteyeres.2018.11.003
Vancouver
Jin Z, Gao M, Deng W, Wu K, Sugita S, Mandai M, et al. Stemming retinal regeneration with pluripotent stem cells. Progress in Retinal and Eye Research. 2018. doi:10.1016/j.preteyeres.2018.11.003.
BibTeX
@article{zibing2018Stemmi,
title = {Stemming retinal regeneration with pluripotent stem cells},
author = {Zi‐Bing Jin and Mei-Ling Gao and Wen-Li Deng and Kun‐Chao Wu and Sunao Sugita and Michiko Mandai and Masayo Takahashi},
journal = {Progress in Retinal and Eye Research},
year = {2018},
doi = {10.1016/j.preteyeres.2018.11.003},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2021
Open access · CC-BY
Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials
Disease Models & Mechanisms 2015
Open access · CC-BY
Cellular models and therapies for age-related macular degeneration
The First Affiliated Hospital with Nanjing Medical University 2025
Open access · US-GOV
Study in Human iPSCs-derived Retinal Pigment Epithelium Cells Transplantation for Advanced (Late-stage) Age-Related Macular Degeneration
Zhonghua shiyan yanke zazhi 2019
Citation only
The research status and the limitations of mesenchymal stem cell-based therapies in age-related macular degeneration
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 2022
Open access · US-GOV
Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells
Nature Communications 2019
Open access · CC-BY